Instructional Course - Requires Course Pass, Additional Registration Required

Instructional Course

005IC - Chemotherapy & Immunotherapy Options for Genitourinary Malignancies: A Primer for the Advanced Practice Provider

Friday, May 18
7:30 AM - 9:30 AM
Location: MCC WEST, 2002

Target audience: APN/PA

Review of current chemotherapy and immunotherapy regimens for genitourinary malignancies, including bladder, renal, and prostate cancers. Indications, outcomes, and toxicities will be discussed as well as clinical trial concepts. Survivorship issues will also be a focus of the session, which will include short, direct didactic lectures as well as a panel discussion with an interactive component. Standard of care chemotherapy regimens (eg MVAC for urothelial carcinoma) as well as newer immunotherapy options (eg checkpoint inhibition for renal cell carcinoma) will be included. Session objectives will include familiarity with systemic therapy regimens for these malignancies as well as their specific expected outcomes and side effects.

Learning Objectives:

Costas D. Lallas

Thomas Jefferson University Hospital

Costas Lallas, MD, FACS is a Vice Chair and Professor of Urology at Thomas Jefferson University Hosptial in Philadelphia, PA. He finished undergraduate studies at Duke University and went on to medical school at Sidney Kimmel (Jefferson) Medical College where he graduated in 1998. He completed a residency in urology at Duke University Medical Center in 2004 and a fellowship at the Mayo Clinic in Arizona in Minimally Invasive Urologic Oncology in 2005. He serves as the Director of Robotic Surgery at Thomas Jefferson University Hospital is the Director of Surgical Simulation for the Rector Clinical Skills and Simulation Center of the Sidney Kimmel Medical College. His clinical practice is primarily urologic oncology with a concentration in minimally invasive surgical management of genitourinary malignancies. He has an interest in undergraduate and graduate education and serves as the director of undergraduate education for the medical school, the associate program director for the urology residency, and the co-director of the fellowship in minimally invasive urologic oncology.


Send Email for Costas Lallas

Anne E. Calvaresi

Thomas Jefferson University

Anne E. Calvaresi, MSN, CRNP completed her BA at the University of Pittsburgh and both her undergraduate and graduate level nursing degrees at Thomas Jefferson University. She is currently enrolled in a Doctor of Nursing Practice program, also at Thomas Jefferson University. She has worked as an outpatient Urologic Nurse practitioner since 2012, focusing primarily on oncologic disease including diagnosis, treatment, follow-up care, and quality of life following treatment. In addition to seeing patients in the outpatient clinic, Anne also spends time in the operating room, functioning as an RN First-assist. She has extensive publications and is chair elect of the Prostate Cancer Health Committee of the Urology Care Foundation. She also serves as a member of the American Urological Association Advanced Practice Provider Membership and Education councils and the Mid-Atlantic American Urological Association APP committee.


Send Email for Anne Calvaresi

Edouard Trabulsi

Sidney Kimmel Medical College at Thomas Jefferson University

Dr. Edouard Trabulsi is a Professor and Vice Chair in the Department of Urology of Sidney Kimmel Medical College at Thomas Jefferson University. He received his Bachelor of Science in Biochemistry cum laude with Distinction in Research from the University of Rochester and completed his medical degree magna cum laude at the State University of New York at Buffalo School of Medicine and Biomedical Sciences. He completed surgery internship, surgery residency, and urology residency at Thomas Jefferson University. He also completed fellowships in urologic oncology and minimally invasive urologic oncology at the Memorial Sloan-Kettering Cancer Center in New York. He specializes in all aspects of urologic oncology and robotic surgery, including prostate cancer, bladder cancer, kidney cancer and testicular cancer. His research interests including advanced imaging for prostate and bladder cancer, including enhanced ultrasound and novel PET imaging, as well as appropriate use of postoperative radiotherapy after radical prostatectomy.

Dr. Trabulsi is Director of the Division of Urologic Oncology in the Department of Urology of Thomas Jefferson University, and Co-Director of both the Genitourinary Multidisciplinary Cancer Center at Kimmel Cancer Center and the Jefferson Prostate Diagnostic Center at Thomas Jefferson University. He is the Genitourinary Cancer Multidisciplinary Group Team leader for clinical trials. He is serves on several national committees of the American Urologic Association (AUA), including the Education Council, the Resident Core Curriculum Committee and the Legislative Affairs Committee. He is currently the President of the Mid-Atlantic Section of the AUA. He is a member of the American Urologic Association, the American College of Surgeons, the American Society of Clinical Oncology, the Society of Urologic Oncology, the American Association of Cancer Research and the American College of Health Care Executives.


Send Email for Edouard Trabulsi


005IC - Chemotherapy & Immunotherapy Options for Genitourinary Malignancies: A Primer for the Advanced Practice Provider


Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Chemotherapy & Immunotherapy Options for Genitourinary Malignancies: A Primer for the Advanced Practice Provider